People with pulmonary arterial hypertension (PAH) who were treated with the inhaled therapy seralutinib in a clinical trial tended to have better improvements in exercise capacity than those given a placebo, data show. However, the difference between the groups failed to meet a prespecified threshold for statistical significance. That…

A few weeks ago, a close friend who also manages a rare disease asked for my thoughts on artificial intelligence (AI) in healthcare. She sounded anxious — AI was suddenly appearing in her medical appointments, and she wasn’t sure what to make of it. This issue has actually been on…

There is a quiet epidemic of loneliness happening in the world. We have replaced effort with ease and lost the health benefits of real human connection. We text instead of talking and share our lives on social media. Emoji hearts, hugs, and thumbs up or down are empty calories that…